Andere Sprachen Sysmex Corporation

Aktien

897966

JP3351100007

6869

Markt geschlossen - Japan Exchange Andere Börsenplätze 08:00:00 16.05.2024			% 5 Tage	% 1. Jan.
2.696 ^JPY	+0,07 %		+1,51 %	+2,91 %

13.02.	Sysmex führt Aktiensplit im Verhältnis 3:1 durch; Aktien steigen um 4%	MT
09.02.	Sysmex Corporation meldet Gewinnergebnisse für die neun Monate bis zum 31. Dezember 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Sysmex : Summary of Consolidated Financial Results for the Fiscal Year Ended March 31, 2024	09.05.
Sysmex : Notice Regarding the Booking of a Loss on Valuation of Shares of Subsidiaries and Associates and a Provision for Loss on Guarantees (Non-Consolidated Financial Statements)	09.05.
Sysmex : Announcement of Executive Change	09.05.
Sysmex : Medicaroid Receives MHLW Approval for the Use of the hinotori™ Surgical Robot System in Thoracic Surgery (Medicaroid)	17.04.
Sysmex : Announcement of Organizational and Personnel Changes	07.03.
Sysmex to Carry Out 3-for-1 Stock Split; Shares Jump 4%	13.02.
Sysmex Corporation Reports Earnings Results for the Nine Months Ended December 31, 2023	09.02.
Sysmex Corporation Reaffirm Year-End Dividend Guidance for the Fiscal Year Ending March 31, 2024	09.02.
Cellavision, Sysmex Expand Hematology Partnership Deal	06.02.
CellaVision and Sysmex Sign Strategic Alliance Agreement	06.02.
CellaVision and Sysmex Corporation Sign Strategic Alliance Agreement	06.02.
Germany’s USU Software Signs Knowledge Management Deal with Japan’s Sysmex	16.01.
Sysmex : Expands Sales of Its Reagents for Blood-based Amyloid β Testing to Europe	25.12.
Sysmex Corporation acquired additional unknown stake in Megakaryon Corporation.	21.12.
Fujirebio and Sysmex sign agreement for the supply of reagent raw materials in the field of Immunoassay	15.12.
Fujirebio Holdings, Inc. and Sysmex Corporation Sign Agreement for the Supply of Reagent Raw Materials in the Field of Immunoassay	14.12.
Sysmex : to Reinforce IVD Instrument Production to Support Total Solutions in Clinical Testing- Expansion of Subsidiary's Manufacturing Factory Ensures Stable Global Supply and Enhanced Laboratory Productivity	05.12.
VCCT Inc announced that it has received ¥600 million in funding from YASKAWA Electric Corporation, Dai-Dan Co., Ltd., Sysmex Corporation	15.11.
Sysmex Unit Plans to Acquire Shares in IVD Medical's Subsidiary	03.11.
Nuevas compras en la cartera Inversor Asia de MarketScreener	24.10.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Sysmex Corporation

Aktien

897966

JP3351100007

6869

Andere Sprachen

Filter